NEW YORK, Sept. 16, 2016 -- Barrack, Rodos & Bacine is investigating the Board of Directors of Standex International Corp. (“Standex” or the “Company”) for possible violations of securities laws and Delaware law relating to the Proxy Statement the Company filed concerning the upcoming annual shareholder meeting to be held on October 27, 2016.
The Proxy Statement filed by Standex with the U.S. Securities and Exchange Commission on September 9, 2016 recommends that Standex shareholders vote to approve five Company proposals. Barrack, Rodos & Bacine’s investigation of these Company proposals indicates that they may contain misleading information that will inhibit a meaningful stockholder vote.
Holders of Standex stock are encouraged to contact Michael Toomey of Barrack Rodos & Bacine, at the following toll-free number: 877-386-3304, or via e-mail to [email protected].
Barrack Rodos & Bacine has more than three decades of experience prosecuting securities and corporation law actions, and has achieved some of the largest recoveries in the history of such litigation.
Michael Toomey 877-386-3304 [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



